Rapid influenza diagnostic tests (RIDTs) are point-of-care medical devices used to detect influenza viruses present in respiratory samples. They enable healthcare professionals to diagnose influenza in approximately 10-15 minutes. RIDTs have advantages over traditional laboratory tests as they eliminate the need for specialized laboratory equipment and trained personnel.
They also allow for early detection and prompt treatment of influenza. The growing awareness regarding early diagnosis and treatment of influenza is a major factor driving the demand for Influenza Diagnostic Tests.
Global Rapid Influenza Diagnostic Tests Market is estimated to be valued at US$ 1.29 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the Global Rapid Influenza Diagnostic Tests are Quidel Corporation, Becton Dickinson, Thermo Fisher Scientific, Abbott Laboratories, F. Hoffmann-La Roche, DiaSorin, Luminex Corporation, Meridian Bioscience, GenMark Diagnostics, Sekisui Diagnostics, and Virax Biolabs.
The increasing prevalence of influenza viruses globally has significantly driven the demand for rapid diagnosis. As per WHO estimates, there are approximately 1 billion cases of influenza reported annually. Rapid diagnostic tests help curb the spread of disease by allowing early detection and treatment.
RIDTs are also witnessing significant technological advancements. Newer products offer enhanced portability, improved sample-to-results time, and simultaneous detection of multiple influenza strains. Portable and lab-on-chip based RIDTs have gained popularity due to convenience.
Market Trends
Point-of-care multiplex testing is a key trend in the RIDTs market. Products which can simultaneously detect influenza A, B, and SARS-CoV-2 are being developed and launched to help healthcare providers efficiently test and differentiate among concurrent respiratory illnesses.
Machine learning and artificial intelligence are also being integrated into RIDTs to offer enhanced data analytics capabilities. Connected devices can stream test data to health records and allow physicians to track infections in real-time.
Market Opportunities
Untapped developing regions remain key opportunities for RIDTs market players. While developed markets in North America and Europe currently dominate the landscape, sales opportunities abound in Asia Pacific and Latin America considering their large population base.
Self-testing using RIDTs presents a lucrative avenue. Over-the-counter RIDT kits which can be used at-home without healthcare assistance are expected to augment market revenues as they promote accessibility and early self-diagnosis.
Impact of COVID-19 on Global Rapid Influenza Diagnostic Tests Market Growth
The COVID-19 pandemic has significantly impacted the growth of the global rapid influenza diagnostic tests market. In the initial phases of the pandemic during 2020-2021, the focus of healthcare resources shifted from influenza testing to COVID-19 testing. This led to reduced sales of rapid influenza diagnostic tests globally. Manufacturers also faced disruptions in global supply chains, affecting production and distribution of these tests.
However, with increasing vaccination rates and better awareness among people post 2022, testing for influenza saw a gradual revival. Healthcare facilities started combining COVID-19 and influenza testing to allow for efficiently distinguishing between infections caused by SARS-CoV-2 and influenza viruses. Market players introduced multiplex tests that can detect and differentiate SARS-CoV-2, influenza A, and influenza B simultaneously. This aided the recovery of the rapid influenza diagnostic tests market.
Going forward, continued co-circulation of SARS-CoV-2 and influenza viruses is expected to drive the demand for differentiation of these respiratory infections. Manufacturers are also focusing on developing affordable and easy-to-use multiplex tests to meet this need. Telehealth adoption and virtual pediatric care during the pandemic exposed more people to rapid influenza diagnostic tests. This trend is likely to have a lasting positive impact on market expansion.
Geographical Regions With Highest Consumption Of Rapid Influenza Diagnostic Tests
North America accounted for the largest share of the global rapid influenza diagnostic tests market in terms of value in 2024. This is attributed to the widespread availability and higher adoption of rapid influenza diagnostic technologies among healthcare providers in the US and Canada. Strong reimbursement policies for influenza tests and presence of leading market players have further supported market growth in the region.
Asia Pacific exhibited the fastest growth in consumption of rapid influenza diagnostic tests during the forecast period. Rising healthcare expenditures, growing middle-class population, and increasing awareness about influenza are driving the Asia Pacific market. In addition, low penetration of molecular diagnostic technologies in emerging countries of the region presents abundant opportunities for rapid influenza diagnostic test manufacturers. China, India, Japan, and South Korea are expected to be at the forefront of the Asia Pacific market expansion.
What Are The Key Data Covered In This Global Rapid Influenza Diagnostic Tests Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Rapid Influenza Diagnostic Tests's growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Rapid Influenza Diagnostic Tests and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global Rapid Influenza Diagnostic Tests Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Rapid Influenza Diagnostic Tests vendors
FAQ’s
Q.1 What are the main factors influencing the Global Rapid Influenza Diagnostic Tests?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Rapid Influenza Diagnostic Tests companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Rapid Influenza Diagnostic Tests’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
Get more insights on this topic: https://www.pressreleasebulletin.com/global-rapid-influenza-diagnostic-tests-market-trend-size-and-demand-2/
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
